Eugia Pharma Receives USFDA Approval for Ephedrine Sulfate Injection 50 mg/mL Single-Dose Vials

Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Ephedrine Sulfate Injection 50 mg/mL Single-Dose Vials.

Indications for this product include:

• Clinically important hypotension occurring in the setting of anesthesia.

Refer to package insert for full prescribing information.